Works matching DE "ACAMPROSATE"

Results: 174

Coupled bioconversion for preparation of N-acetyl- d-neuraminic acid using immobilized N-acetyl- d-glucosamine-2-epimerase and N-acetyl- d-neuraminic acid lyase.

Published in:

Applied Microbiology & Biotechnology, 2010, v. 85, n. 5, p. 1383, doi. 10.1007/s00253-009-2163-9

By:

Shiyuan Hu;
Jun Chen;
Zhongyi Yang;
Lijun Shao;
Hua Bai;
Jiali Luo;
Weihong Jiang;
Yunliu Yang

Publication type:

Article

Therapy and Supportive Care of Alcoholics: Guidelines for Practitioners.

Published in:

Digestive Diseases, 2005, v. 23, n. 3/4, p. 304, doi. 10.1159/000090178

By:

Kienast, Thorsten;
Heinz, Andreas

Publication type:

Article

HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners.

Published in:

American Journal of Drug & Alcohol Abuse, 2011, v. 37, n. 1, p. 12, doi. 10.3109/00952990.2010.540280

By:

Springer, Sandra A.;
Azar, Marwan M.;
Altice, Frederick L.

Publication type:

Article

The Efficacy of Acamprosate and Naltrexone in the Treatment of Alcohol Dependence: A Relative Benefits Analysis of Randomized Controlled Trials.

Published in:

American Journal of Drug & Alcohol Abuse, 2008, v. 34, n. 4, p. 449, doi. 10.1080/00952990802082198

By:

Snyder, James L.;
Bowers, Thomas G.

Publication type:

Article

Acamprosate: A Review of Its Use in Alcohol Dependence.

Published in:

2015

By:

Plosker, Greg

Publication type:

Journal Article

Retrospective Review of Acute Acamprosate Exposures to a Poison Control System.

Published in:

American Journal on Addictions, 2010, v. 19, n. 5, p. 462, doi. 10.1111/j.1521-0391.2010.00071.x

By:

Nordt, Sean Patrick;
Scaduto, Lora;
Clark, Richard F.;
Cantrell, F. Lee

Publication type:

Article

Acamprosate Efficacy in Alcohol-Dependent Patients: Summary of Results from Three Pivotal Trials.

Published in:

American Journal on Addictions, 2008, v. 17, n. 1, p. 70, doi. 10.1080/10550490701756120

By:

Kranzler, Henry R.;
Gage, Allyson

Publication type:

Article

...HAROLD CLIFTON URSCHEL III, MD: an interview with the editor on his passion to prevent and cure addiction.

Published in:

2011

By:

Urschel III, Harold Clifton;
Roberts, William Clifford

Publication type:

Interview

Nalmefen.

Published in:

Der Nervenarzt, 2014, v. 85, n. 5, p. 578, doi. 10.1007/s00115-013-3843-3

By:

Soyka, M.

Publication type:

Article

Rückfallprävention bei Alkoholabhängigkeit: Acamprosat und Naltrexon als kombinierte pharmakologische Strategie.

Published in:

Der Nervenarzt, 2013, v. 84, n. 5, p. 584, doi. 10.1007/s00115-012-3633-3

By:

Gahr, M.;
Kölle, M.A.;
Schönfeldt-Lecuona, C.

Publication type:

Article

Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence.

Published in:

Acta Neuropsychiatrica, 2004, v. 16, n. 5, p. 233, doi. 10.1111/j.0924-2708.2004.00093.x

By:

Kiefer, F.;
Andersohn, F.;
Otte, C.;
Wolf, K.;
Jahn, H.;
Wiedemann, K.

Publication type:

Article

How effective are pharmacologic agents for alcoholism.

Published in:

Journal of Family Practice, 2002, v. 51, n. 6, p. 577

By:

Hunt, R. Randy

Publication type:

Article

Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 7, p. 865, doi. 10.1111/apt.13965

By:

Goh, E. T.;
Morgan, M. Y.

Publication type:

Article

Acamprosate and its efficacy in treating alcohol dependent adolescents.

Published in:

European Child & Adolescent Psychiatry, 2003, v. 12, n. 3, p. 144, doi. 10.1007/s00787-003-0327-1

By:

Niederhofer, Helmut;
Staffen, Wolfgang

Publication type:

Article

Acamprosate-induced Extrapyramidal Symptoms in an Elderly Patient with Alcohol Dependence.

Published in:

Clinical Psychopharmacology & Neuroscience, 2014, v. 12, n. 2, p. 166, doi. 10.9758/cpn.2014.12.2.166

By:

Jungmin Woo;
Hyo-Deog Rim

Publication type:

Article

Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action.

Published in:

CNS Drugs, 2005, v. 19, n. 6, p. 517, doi. 10.2165/00023210-200519060-00004

By:

Philippe De Witte;
Littleton, John;
Parot, Philippe;
Koob, George

Publication type:

Article

Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.

Published in:

2005

By:

Scott, Lesley J.;
Figgitt, David P.;
Keam, Susan J.;
Waugh, John

Publication type:

journal article

Pharmacotherapy of Alcohol Dependence: A Review of the Clinical Data.

Published in:

CNS Drugs, 2004, v. 18, n. 8, p. 485, doi. 10.2165/00023210-200418080-00002

By:

Mann, Karl

Publication type:

Article

The Changing Face of Alcoholism Treatment.

Published in:

Psychiatric Times, 2007, v. 24, n. 4, p. 19

By:

Heilig, Markus

Publication type:

Article

ASAM Speakers Urge Medication Use for Alcoholism.

Published in:

Psychiatric Times, 2005, v. 22, n. 13, p. 50

By:

Bender, Kenneth J.

Publication type:

Article

Treating Alcohol Abuse and Dependence.

Published in:

Psychiatric Times, 2005, v. 22, n. 7, p. 7

By:

Bowes, Mark P.

Publication type:

Article

N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease.

Published in:

PLoS ONE, 2008, v. 3, n. 9, p. 1, doi. 10.1371/journal.pone.0003108

By:

Toiber, Debra;
Berson, Amit;
Greenberg, David;
Melamed-Book, Naomi;
Diamant, Sophia;
Soreq, Hermona

Publication type:

Article

Expectancy in Double-Blind Placebo-Controlled Trials: An Example from Alcohol Dependence.

Published in:

Psychotherapy & Psychosomatics, 2009, v. 78, n. 3, p. 167, doi. 10.1159/000206871

By:

Ben Colagiuri;
Kirsten Morley;
Robert Boakes;
Paul Haber

Publication type:

Article

N -Acetylcysteine Antagonizes the Development But Does Not Reverse ACTH-Induced Hypertension in the Rat.

Published in:

Clinical & Experimental Hypertension, 2006, v. 28, n. 2, p. 73, doi. 10.1080/10641960500468219

By:

Mondo, Charles K.;
Zhang, Yi;
de Macedo Possamai, Vinicius;
Miao, Yuchun;
Schyvens, Christopher G.;
McKenzie, Katja U.S.;
Hu, Lexian;
Guo, Zhijun;
Whitworth, Judith A.

Publication type:

Article

The LuxR family protein SpnR functions as a negative regulator of N-acylhomoserine lactone-dependent quorum sensing in Serratia marcescens.

Published in:

Molecular Microbiology, 2002, v. 45, n. 6, p. 1655, doi. 10.1046/j.1365-2958.2002.03117.x

By:

Horng, Yu-Tze;
Deng, Su-Chen;
Daykin, Mavis;
Soo, Po-Chi;
Wei, Jun-Rong;
Luh, Kwen-Tay;
Ho, Shen-Wu;
Swift, Simon;
Lai, Hsin-Chih;
Williams, Paul

Publication type:

Article

Calcium chloride mimics the effects of acamprosate on cognitive deficits in chronic alcohol-exposed mice.

Published in:

Psychopharmacology, 2018, v. 235, n. 7, p. 2027, doi. 10.1007/s00213-018-4900-1

By:

Pradhan, Grishma;
Melugin, Patrick R.;
Wu, Fei;
Fang, Hannah M.;
Weber, Rachel;
Kroener, Sven

Publication type:

Article

Clinical pharmacokinetics of acamprosate.

Published in:

1998

By:

Saivin, S.;
Hulot, T.;
Chabac, S.;
Potgieter, A.;
Durbin, P.;
Houin, G.

Publication type:

journal article

Bringing Patient-Centered Care to Patients With Alcohol Use Disorders.

Published in:

2014

By:

Bradley, Katharine A.;
Kivlahan, Daniel R.

Publication type:

Editorial

Prevalence and safety of acamprosate use in pregnant alcohol‐dependent women in New South Wales, Australia.

Published in:

Addiction, 2019, v. 114, n. 2, p. 206, doi. 10.1111/add.14429

By:

Kelty, Erin;
Tran, Duong;
Lavin, Tina;
Preen, David B.;
Hulse, Gary;
Havard, Alys

Publication type:

Article

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

Published in:

Addiction, 2008, v. 103, n. 6, p. 953, doi. 10.1111/j.1360-0443.2008.02215.x

By:

Richardson, Kylie;
Baillie, Andrew;
Reid, Sophie;
Morley, Kirsten;
Teesson, Maree;
Sannibale, Claudia;
Weltman, Martin;
Haber, Paul

Publication type:

Article

[Commentary] DRUG TREATMENT—NOT AS USELESS AS IT SEEMS.

Published in:

Addiction, 2008, v. 103, n. 5, p. 707, doi. 10.1111/j.1360-0443.2008.02152.x

By:

KALANT, HAROLD

Publication type:

Article

Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial.

Published in:

Addiction, 2006, v. 101, n. 10, p. 1451, doi. 10.1111/j.1360-0443.2006.01555.x

By:

Morley, Kirsten C.;
Teesson, Maree;
Reid, Sophie C.;
Sannibale, Claudia;
Thomson, Clare;
Phung, Nghi;
Weltman, Martin;
Bell, James R.;
Richardson, Kylie;
Haber, Paul S.

Publication type:

Article

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.

Published in:

Addiction, 2004, v. 99, n. 7, p. 811, doi. 10.1111/j.1360-0443.2004.00763.x

By:

Carmen, Bouza;
Angeles, Magro;
Ana, Muñoz;
María, Amate José

Publication type:

Article

FOR DEBATE Does disulfiram have a role in alcoholism treatment today?

Published in:

2004

By:

FULLER, RICHARD K.;
GORDIS, ENOCH

Publication type:

Editorial

Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.

Published in:

2012

By:

Witkiewitz, Katie;
Saville, Kimber;
Hamreus, Kacie

Publication type:

journal article

Pharmacodynamic Effects of Acamprosate on Markers of Cerebral Function in Alcohol-Dependent Subjects Administered as Pretreatment and during Alcohol Abstinence.

Published in:

Neuropsychobiology, 2004, v. 50, n. 1, p. 71, doi. 10.1159/000077944

By:

Boeijinga, P. H.;
Parot, P.;
Soufflet, L.;
Landron, F.;
Danel, T.;
Gendre, I.;
Muzet, M.;
Demazières, A.;
Luthringer, R.

Publication type:

Article

Acamprosate Reduces Motor Cortex Excitability Determined by Transcranial Magnetic Stimulation.

Published in:

Neuropsychobiology, 2000, v. 42, n. 4, p. 183, doi. 10.1159/000026691

By:

Wohlfarth, Kai;
Schneider, Udo;
Haacker, Tilmann;
Schubert, Margot;
Schulze-Bonhage, Andreas;
Zedler, Markus;
Emrich, Hinderk M.;
Dengler, Reinhard;
Rollnik, Jens D.

Publication type:

Article

New Light on the Mechanism of Acamprosate, a Taurine Derivative that Prevents Relapse in Alcoholics.

Published in:

1998

By:

Littleton, J.M.;
Qatari, M. Al;
Lim, L.;
Bourchenafa, O.

Publication type:

Abstract

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.

Published in:

World Journal of Biological Psychiatry, 2008, v. 9, n. 1, p. 6, doi. 10.1080/15622970801896390

By:

Soyka, Michael;
Kranzler, Henry R.;
Berglund, Mats;
Gorelick, David;
Hesselbrock, Victor;
Johnson, Bankole A.;
Möller, Hans-Jürgen;
THE WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR SUBSTANCE USE DISORDERS

Publication type:

Article

Long-term drug treatment of patients with alcohol dependence.

Published in:

Australian Prescriber, 2015, v. 38, n. 2, p. 41, doi. 10.18773/austprescr.2015.015

By:

Crowley, Philip

Publication type:

Article

Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Published in:

Neurotoxicity Research, 2016, v. 30, n. 4, p. 698, doi. 10.1007/s12640-016-9655-z

By:

Kleczkowska, Patrycja;
Smaga, Irena;
Filip, Małgorzata;
Bujalska-Zadrozny, Magdalena

Publication type:

Article

Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.

Published in:: International Journal of Neuropsychopharmacology, 2008, v. 11, n. 6, p. 775, doi. 10.1017/S1461145708008584
Publication type:: Article

Pharmacogenomics of Alcohol Addiction: Personalizing Pharmacologic Treatment of Alcohol Dependence.

Published in:

Hospital Pharmacology: International Multidisciplinary Journal, 2014, v. 1, n. 3, p. 147, doi. 10.5937/hpimj1403147r

By:

Ragia, Georgia;
Manolopoulos, Vangelis G.

Publication type:

Article

Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.

Published in:

Scientific Reports, 2015, p. 16084, doi. 10.1038/srep16084

By:

Hajj, Rodolphe;
Milet, Aude;
Toulorge, Damien;
Cholet, Nathalie;
Laffaire, Julien;
Foucquier, Julie;
Robelet, Sandra;
Mitry, Richard;
Guedj, Mickael;
Nabirotchkin, Serguei;
Chumakov, Ilya;
Cohen, Daniel

Publication type:

Article

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

Published in:

Psychopharmacology, 2000, v. 149, n. 4, p. 327, doi. 10.1007/s002130000371

By:

Johnson, B. A.;
Ait-Daoud, N.

Publication type:

Article

Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze.

Published in:

Psychopharmacology, 2000, v. 147, n. 4, p. 403, doi. 10.1007/s002130050009

By:

Cole, J. C.;
Littleton, J. M.;
Little, H. J.

Publication type:

Article

Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice.

Published in:

Psychopharmacology, 1998, v. 140, n. 4, p. 421, doi. 10.1007/s002130050785

By:

Naassila, Mickaël;
Legrand, Elisabeth;
d'Alche-Birée, Francoise;
Daoust, M.

Publication type:

Article

Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress.

Published in:

Psychopharmacology, 1998, v. 139, n. 4, p. 391, doi. 10.1007/s002130050730

By:

Spanagel, R.;
Sillaber, Inge;
Zieglgänsberger, Walter;
Corrigall, William A.;
Stewart, Jane;
Shaham, Yavin

Publication type:

Article

Advances in development of medications for alcoholism treatment.

Published in:

Psychopharmacology, 1998, v. 139, n. 1/2, p. 20, doi. 10.1007/s002130050686

By:

Litten, R. Z.;
Allen, John P.

Publication type:

Article

The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine.

Published in:

2003

By:

Mcgeehan, Andrew J.;
Olive, M. Foster

Publication type:

journal article